Discontinuation of anti-hypertensive drugs increases 11-year cardiovascular mortality risk in community-dwelling elderly (the Bambuí Cohort Study of Ageing)-Reference-Cited by-同舟云学术

Discontinuation of anti-hypertensive drugs increases 11-year cardiovascular mortality risk in community-dwelling elderly (the Bambuí Cohort Study of Ageing)

Published:2014-07-16 Issue:1 Volume:14 Page:
ISSN:1471-2458
Container-title:BMC Public Health
language:en
Short-container-title:BMC Public Health

Author:

Correa Leite Maria Lea,Firmo Joselia OA,Loyola Filho Antonio Ignacio,Lima-Costa Maria Fernanda

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health

Link

http://link.springer.com/content/pdf/10.1186/1471-2458-14-725.pdf

Reference40 articles.

1. Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS, Ferdinand KC, Forciea MA, Frishman WH, Jaigobin C, Kosris JB, Mancia G, Oparil S, Ortiz E, Reisin E, Rich MW, Schocken DD, Weber MA, Wesley DJ: ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation. 2011, 123: 2434-2506. 10.1161/CIR.0b013e31821daaf6.

2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J: Global burden of hypertension: analysis of worldwide data. Lancet. 2005, 365: 217-223. 10.1016/S0140-6736(05)17741-1.

3. World Health Organization: Reducing risks, promoting healthy life. The World Health Report 2002. 2002, Geneva: World Health Organization

4. Kannel WB: Hypertension: reflections on risks and prognostication. Med Clin North Am. 2009, 93: 541-548. 10.1016/j.mcna.2009.02.006.

5. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL: European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J. 2007, 28: 2375-2414.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Longitudinal Patterns and Predictors of Medicine Use in Residential Aged Care Using Group‐Based Trajectory Modeling: The “MEDTRAC‐Cardiovascular” Longitudinal Cohort Study;Pharmacoepidemiology and Drug Safety;2024-08

2. Hypertension and Drug Adherence in the Elderly;Frontiers in Cardiovascular Medicine;2020-04-07

3. Visit-to-visit variability of metabolic parameters and risk of heart failure: A nationwide population-based study;International Journal of Cardiology;2019-10

4. Risk of acute myocardial infarction after discontinuation of antihypertensive agents: a case–control study;Journal of Human Hypertension;2017-03-23

5. Adherence of Patients to Antihypertensive Therapy With Combination of Perindopril and Indapamide According to Data of the FORSAGE Program;KARDIOLOGIYA;2017